Last reviewed · How we verify

NCT05757388

Efficacy of Parecoxib Combined With Paracetamol in Mastectomy

Status unknown NA Last updated 14 April 2023
What this trial tests

NA trial testing Parecoxib + paracetamol in Post Operative Pain in 60 participants. Status unknown.

Timeline
28 March 2023
Primary endpoint
1 May 2023
10 May 2023

Quick facts

Lead sponsorKhon Kaen University
PhaseNA
StatusStatus unknown
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingtriple
Primary purposetreatment
Enrollment60
Start date28 March 2023
Primary completion1 May 2023
Estimated completion10 May 2023
Sites1 location across Thailand

Drugs / interventions tested

Conditions studied

Sponsor

Khon Kaen University

Who can join

Adults 18 to 65, female only, with Post Operative Pain. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Patients undergoing breast cancer surgery experience persistent pain after surgery and subsequent development of chronic pain. Parecoxib or paracetamol has been reported to reduce postoperative pain in mastectomy. The investigators aim to assess the effectiveness of the perioperative administration of parecoxib combined with paracetamol to reduce postoperative acute and subacute breast surgical pain.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Post Operative Pain

Currently open trials in the same condition.

Other Khon Kaen University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05757388.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing